电荷中和的多 (β-氨基) 多复合纳米粒子用于输送自我放大RNA
Nazgol Karimi Dastgerdi1,2, Nurcan Gumus1, Hulya Bayraktutan1
1Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.
Nanoscale advances
|February 29, 2024
概括
这项研究通过将聚合物与γ-多聚胺酸 (γ-PGA) 结合,改善了自我放大RNA (saRNA) 的传递. 这提高了saRNA转染效率和降低了毒性,为基于RNA的治疗提供了一个有前途的策略.
科学领域:
- 生物技术是生物技术.
- 纳米技术纳米技术
- 分子生物学分子生物学
背景情况:
- 与mRNA相比,自放大RNA (saRNA) 由于剂量要求较低,因此具有治疗潜力.
- 有效的输送载体对于saRNA保护和细胞转染至关重要.
- 传统的多离子递送系统通常会由于高正电荷密度而引起细胞毒性.
研究的目的:
- 为了提高基于聚β-氨基的saRNA输送载体的功效和耐受性.
- 调查聚化saRNA多重复合物与基 γ-多重胺酸 (γ-PGA) 联合配制的效果.
主要方法:
- 从1,6-hexanediol-diacrylate (HDDA) 和4-aminobutanol (ABOL) 中制备的聚-β-氨基.
- 二元多复合体 (聚合物和saRNA) 的形成和表征.
- 准备和评估包含γ-PGA,saRNA和pHDDA-ABOL的三元复合体.
主要成果:
- γ-PGA整合显著提高了HEK293T和A431细胞中的saRNA转染疗效.
- 三级复合体在moDC,NIH3T3和A431细胞中显示出降低的泽塔潜力和降低的毒性.
- γ-PGA提高了体稳定性,在结解周期后保持低的多分散指数 (PDI).
结论:
- 与 γ-PGA 共同配制多性 saRNA 多复合体是一种可行的策略,以改善交付.
- 这种方法提高了转染效率并降低了细胞毒性,解决了saRNA传递的关键挑战.
- 这些发现表明,开发更安全,更有效的 in vitro saRNA 输送配方是一种有希望的方法.
相关概念视频
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K


